Lisa M Barroilhet

10PUBLICATIONS

68CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 18, 2026

An autologous cell-based therapeutic vaccine expressing IL6/1 fusokine drives robust anti-tumor response against ovarian cancer.

|May 12, 2026

Benign Lesions Scored as O-RADS US v2022 4 and 5 Categories: Prevalence and Morphologic Analysis.

|Dec 30, 2025

Early Detection and Prevention of Ovarian Cancer.

Lauren Montemorano, Laura Huffman, Lisa Barroilhet

|Dec 04, 2025

SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.

Bradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto

|Oct 06, 2025

Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer.

Britt K Erickson, Howard Bailey, Rebecca C Arend

|Oct 08, 2024

The Ovarian-Adnexal Reporting and Data System (O-RADS) US Score Effect on Surgical Resection Rate.

Luyao Shen, Elizabeth A Sadowski, Akshya Gupta

Pageof 2

Frequent Collaborators

Akshya Gupta

Priyanka Jha

Elizabeth Sadowski

Yang Guo

Katherine E Maturen

Krupa Patel-Lippmann

Hanna M Zafar

Aya Kamaya

Neha Antil

Luyao Shen

Frequent Collaborators

Akshya Gupta

Priyanka Jha

Elizabeth Sadowski

Yang Guo